MicroRNA profiling in mucosal biopsies of eosinophilic esophagitis patients pre and post treatment with steroids and relationship with mRNA targets

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Lu, Shaolei ^a   Mukkada, Vincent A ^b   Mangray, Shamlal ^a   Cleveland, Kelly ^a   Shillingford, Nick ^a   Schorl, Christoph ^a   Brodsky, Alexander S ^a   Resnick, Murray B ^a  

^a BROWN UNIVERSITY   (United States)

^b HASBRO CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; FLUTICASONE; GLUCOCORTICOID; MESSENGER RNA; MICRORNA; MICRORNA 142 3P; MICRORNA 145; MICRORNA 146A; MICRORNA 146B 5B; MICRORNA 146B 5P; MICRORNA 203; MICRORNA 21; MICRORNA 214; MICRORNA 489; UNCLASSIFIED DRUG;

ADOLESCENT; ALLERGY; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EOSINOPHILIC ESOPHAGITIS; ESOPHAGUS MUCOSA; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE TARGETING; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE GENE; IMMUNOREGULATION; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA SEQUENCE; SCHOOL CHILD; TRANSCRIPTOMICS; UPREGULATION; VALIDATION PROCESS;

ADOLESCENT; BIOPSY; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COMPUTATIONAL BIOLOGY; EOSINOPHILIC ESOPHAGITIS; ESOPHAGUS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY; INFANT; MALE; MICRORNAS; MUCOUS MEMBRANE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEROIDS;

EID: 84863991618     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040676     Document Type: Article

References (38)

1. Liacouras CA, Furuta GT, Hirano I, Atkins D, Attwood SE, et al. (2011) Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 128: 3-20.
2. Abonia JP, Rothenberg ME, (2012) Eosinophilic esophagitis: rapidly advancing insights. Annu Rev Med 63: 421-434.
3. Blanchard C, Wang N, Stringer KF, Mishra A, Fulkerson PC, et al. (2006) Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest 116: 536-547.
4. Blanchard C, Mingler MK, Vicario M, Abonia JP, Wu YY, et al. (2007) IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucosteroids. J Allergy Clin Immunol 120: 1292-1300.
5. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism and function. Cell 116: 281-297.
6. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ, (2008) miRBase: tools for micrRNA genomics. Nucleic Acids Res 36: D154-158.
7. O'Connell RM, Rao DS, Baltimore D, (2012) MicroRNA regulation of inflammatory responses. Annu Rev Immunol 30: 295-312.
8. Mattes J, Collison A, Plank M, Phipps S, Foster PS, (2009) Antagonism of microRNA-126 suppresses the effector function of TH2 cells and the development of allergic airways disease. Proc Natl Acad Sci USA 106: 18704-18709.
9. Lu TX, Munitz A, Rothenberg ME, (2009) MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression. J Immunol 182: 4994-5002.
10. Collison A, Herbert C, Siegle JS, Mattes J, Foster PS, et al. (2011) Altered expression of microRNA in the airway wall in chronic asthma: miR-126 as a potential therapeutic target. BMC Pulm Med 11: 29.
11. Collison A, Mattes J, Plank M, Foster PS, (2011) Inhibition of house dust mite-induced allergic airways disease by antagonism of microRNA-145 is comparable to glucocorticoid treatment. J Allergy Clin Immunol 128: 160-167.
12. Garbacki N, Di Valentin E, Huynh-Thu VA, Geurts P, Irrthum A, et al. (2011) MicroRNAs profiling in murine models of acute and chronic asthma: A relationship with mRNAs targets. PloS ONE 6: e16509.
13. Lu TX, Sherrill JD, Wen T, Plassard AJ, Besse JA, et al. (2012) MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids and assessment as disease markers. J Allergy Clin Immunol 129: 1064-1075.
14. Resnick MB, Sabo E, Meitner PA, Kim SS, Cho Y, et al. (2006) Global analysis of the human gastric epithelial transcriptome altered by Helicobacter pylori eradication in vitro. Gut 55: 1717-1724.
15. Allantaz F, Cheng DT, Bergauer T, Ravindran P, Rossier MF, et al. (2012) Expression profiling of human immune cell subsets identifies miRNA-mRNA regulatory relationships correlated with cell type specific expression. PLoS ONE 7: 29979.
16. Mathé EA, Nguyen GH, Bowman ED, Zhao Y, Budhu A, et al. (2009) MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin Cancer Res 15: 6192-6200.
17. Kan T, Meltzer SJ, (2009) MicroRNAs in Barrett's esophagus and esophageal adenocarcinoma. Curr Opin Pharmacol 9: 727-732.
18. Godwin JG, Ge X, Stephen K, Jurisch A, Tullius SG, et al. (2010) Identification of a microRNA signature of renal ischemia perfusion injury. Proc Natl Acad Sci USA 107: 14339-14344.
19. Denby L, Ramdas V, McBride MW, Wang J, Robinson H, et al. (2011) miR-21 and miR-214 are consistently modulated during renal injury in rodent models. Am J Pathol 179: 661-672.
20. Hackett TL, Warner SM, Stefanowicz D, Shaheen F, Pechkovsky DV, et al. (2009) Induction of epithelial-mesenchymal transition in primary airway epithelial cells from patients with asthma by transforming growth factor beta. Am J Respir Crit Care Med 180: 122-133.
21. Johnson JR, Roos A, Berg T, Nord M, Fuxe J, (2011) Chronic respiratory aeroallergen exposure to mice induces epithelial-mesenchymal transition in the larger airways. PLoS One 6: e16175.
22. Straumann A, Spichtin HP, Grize L, (2003) Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years. Gastroenterology 125: 1660-1669.
23. Aceves SS, Newbury RO, Dohil R, Bastian JF, Broide DH, (2007) Esophageal remodeling in pediatric eosinophilic esophagitis. J Allergy Clin Immunol. 119: 206-212.
24. Chehade M, Sampson HA, Morotti RA, Magid MS, (2007) Esophageal subepithelial fibrosis in children with eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 45: 319-328.
25. Kagalwalla AF, Akhtar N, Woodruff SA, Rea B, Masterson JC, et al. (2012) Eosinophilic Esophagitis: Epithelial Mesenchymal Transition Contributes to Esophageal Remodeling and Reverses With Treatment. Journal of Allergy and Clinical Immunology 129: 1387-1396.
26. Hua Z, Chun W, Fang-Yuan C, (2011) MicroRNA-146a and hemopoietic disorders. Int J Hematol 94: 224-229.
27. Li N, Xu X, Xiao B, Zhu ED, Li BS, et al. (2011) H. pylori related proinflammatory cytokines contribute to the induction of miR-146a in human gastric epithelial cells. Mol Biol Rep 39: 4655-4661.
28. Taganov KD, Boldin MP, Chang KJ, Baltimore D, (2006) NF-kappa-B-dependent induction of microRNA miR-146, an inhibitor targeted to signalling proteins of innate immune responses. Proc Natl Acad Sci USA 103: 12481-12486.
29. Persad R, Huynh HQ, Hao L, Ha JR, Sergi C, et al. (2012) Angiogenic remodeling in pediatric eosinophilic esophagitis is associated with increased levels of VEGFA, angiogenin, IL-8 and activation of the TNF-a-NFkB pathway. J Pediatr Gastroenterol Nutr Feb 10 EPUB.
30. Gavett Sh, O'Hearn DJ, Huang SK, Finkelman FD, Wills-Karp M, (1995) Interleukin 12 inhibits antigen induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med 182: 1527-1536.
31. Liu G, Friggeri A, Yang Y, Milosevic J, Ding Q, et al. (2010) miR-21 mediated fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med 207: 1589-1597.
32. Zarjou A, Yang S, Abraham E, Agarwal A, Liu G, (2011) Identification of a microRNA signature in renal fibrosis: role of miR-21. Am J Physiol Renal Physiol 301: 793-801.
33. Pieztsch J, Hoppmann S, (2009) Human S100A12: a novel key player in inflammation? Amino Acids 36: 381-389.
34. Sato N, Hitomi J, (2002) S100P expression in human esophageal epithelial cells: Human esophageal epithelial cells sequentially produce different S100 proteins in the process of differentiation. Anat Rec 267: 60-69.
35. Chu HW, Balzar S, Westcott JY, Trudeau JB, Sun Y, et al. (2002) Expression and activation of 15-lipoxygenase pathway in severe asthma: relationship to eosinophilic phenotype and collagen deposition. Clin Exp Allergy 32: 1558-1565.
36. Sigal E, Grunberger D, Cashman JR, Craik CS, Caughey GH, et al. (1988) Arachidonate 15-lipoxygenase from human eosinophil-enriched leukocytes: partial purification and properties. Biochem Biophys Res Commun 150: 376-383.
37. Nadel JA, Conrad DJ, Ueki IF, Schuster A, Sigal E, (1991) Immunocytochemical localization of arachidonate 15-lipoxygenase in erythrocytes, leukocytes, and airway cells. J Clin Invest 87: 1139-1145.
38. Macmillan DK, Hill E, Sala A, Sigal E, Shuman T, et al. (1994) Eosinophil 15-lipoxygenase is a leukotriene A4 synthase. J Biol Chem 269: 26663-26668.